VitaNova Life Sciences Corporation VNOV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.28% | 104.04% | 188.47% | 465.22% | 639.12% |
| Total Receivables | -68.76% | -42.64% | 1,760.00% | 1,429.64% | -- |
| Inventory | 3,210.99% | 138.91% | -30.16% | -96.27% | -95.74% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -99.38% | -99.38% | -98.82% | -73.96% | -80.82% |
| Total Current Assets | -0.85% | 7.72% | 74.99% | 85.59% | 86.73% |
|
|
|||||
| Total Current Assets | -0.85% | 7.72% | 74.99% | 85.59% | 86.73% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -0.14% | 8.43% | 74.99% | 85.59% | 86.73% |
|
|
|||||
| Total Accounts Payable | 82.20% | -- | 50.97% | 142.80% | 0.30% |
| Total Accrued Expenses | -- | 29.72% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -65.15% | -62.33% | 591.71% | 655.26% | 308.50% |
| Total Other Current Liabilities | -65.15% | -62.33% | 591.71% | 655.26% | 308.50% |
| Total Current Liabilities | -17.97% | 13.87% | 115.23% | 95.67% | 90.57% |
|
|
|||||
| Total Current Liabilities | -17.97% | 13.87% | 115.23% | 95.67% | 90.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -17.97% | 13.87% | 115.23% | 95.67% | 90.57% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retained Earnings | -13.89% | -4.30% | 1,105.93% | 15,407.14% | 2,244.65% |
| Treasury Stock & Other | 5,980.00% | 5,980.00% | 0.00% | 20.00% | 66.67% |
| Total Common Equity | 3.51% | 7.44% | 67.25% | 83.42% | 85.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.51% | 7.44% | 67.25% | 83.42% | 85.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.51% | 7.44% | 67.25% | 83.42% | 85.96% |
|
|
|||||